Validity and Reliability of Outcome Measurement Instruments for Cognitive Function in Alzheimer’s Disease: A Systematic Review
Dementia and Geriatric Cognitive Disorders · 2025
DOI: 10.1159/000545907 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Dementia and Geriatric Cognitive Disorders, 2025. Verfasst von Zhe-Zuo Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic Research In Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuropsychological Tests, Cognition, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Demenz
Abstract (Originalsprache)
Introduction
In this systematic review, we aimed to identify suitable measurement tools for screening individuals for cognitive impairment in Alzheimer’s disease (AD). We conducted a comprehensive evaluation of the reliability and validity of cognitive function assessment instruments. We offer insightful suggestions for further research on cognitive function scale development and clinical researchers in AD.
Methods
We searched the PUBMED and CNKI databases for studies aimed at developing or evaluating the validity or reliability of cognitive function assessment scales. The methodological quality of the studies was assessed using the consensus-based standards for the selection of health measurement instruments (COSMIN) according to the ‘worst score counts’ principle. Subsequently, the measurement properties were rated qualitatively. Results were rated using the modified Grading of Recommendations, Assessment, Development, and Evaluation. Recommendations were categorized into four levels: A, B, C, and D.
Results
We retrieved a total of 804 studies. Following screening, a total of 62 articles were included, which reported 49 cognitive impairment assessment scales. The methodological quality of studies ranged from inadequate to very good, and the measurement properties varied from sufficient (+) to indeterminate (?). We found that the ADAS-Cog, MoCA, BPMSE, CDR and the other 28 scales had sufficient validity and reliability.
Conclusion
Our evaluation according to the COSMIN guidelines suggested that the ADAS-Cog, MoCA, BPMSE, CDR and MMSE could be used to assess the degree of cognitive impairment in patients with AD. When developing cognitive function assessment scales, factors such as time and linguistic and cultural differences could be carefully considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Basic Research In Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
- Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
- Institute of Basic Research In Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China, tcmcec@126.com.
- BinZhou Medical University, Yantai, China.
- Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China.
Zitieren
APA
Zhang, Z. Z., Lyu, X. Y., Dai, X. W., Cong, J. N., & Yang, F. X. (2025). Validity and Reliability of Outcome Measurement Instruments for Cognitive Function in Alzheimer’s Disease: A Systematic Review. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000545907
Vancouver
Zhang ZZ, Lyu XY, Dai XW, Cong JN, Yang FX. Validity and Reliability of Outcome Measurement Instruments for Cognitive Function in Alzheimer’s Disease: A Systematic Review. Dementia and Geriatric Cognitive Disorders. 2025. doi:10.1159/000545907
BibTeX
@article{Zhang2025,
author = {Zhang, Zhe-Zuo and Lyu, Xiao-Ying and Dai, Xiang-Wei and Cong, Jian-Ni and Yang, Fu-Xia},
title = {Validity and Reliability of Outcome Measurement Instruments for Cognitive Function in Alzheimer’s Disease: A Systematic Review},
journal = {Dementia and Geriatric Cognitive Disorders},
year = {2025},
doi = {10.1159/000545907}
}
EUVIMED